- $680.63m
- $658.47m
Brief: Nuvectis Pharma Inc Announces Approximately $15.9 Million Private Placement
Nuvectis Pharma rises on FDA nod for cancer therapy
Brief: Nuvectis Pharma Announces FDA Clearance Of Ind For NXP800
Brief: Nuvectis Pharma Announces Positive Data For Nxp900 In A Preclinical Model Of Group 4 Medulloblastoma, A Type Of Brain Cancer That Affects Predominantly Pediatric Patients
Brief: Nuvectis Pharma Inc Reports First Quarter 2022 Financial Results
Brief: Nuvectis Pharma Says Michael Carson Is Replacing Uri Ben-Or Who Served As Interim Chief Financial Officer
Brief: Nuvectis Pharma Reports Fiscal Year 2021 Financial Results
U.S. STOCKS ON THE MOVE-Meritor, Homology Medicines, Zosano Pharma
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:08 PM
NASDAQ RESUMED AT 11:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:43 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
U.S. STOCKS ON THE MOVE-Amazon, Ford, Clorox, oil stocks
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM